Clinical trial
Evaluation of the Bexa Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection
NCT06643767 is registered in ClinicalTrials.gov with Sure, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Bexa Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection
- Lead sponsor
- Sure, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 16, 2024
- Completion date
- May 31, 2025
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer